Analysts’ Updated EPS Estimates for January, 29th (ABBV, ACST, APD, ARZTY, BABA, BMY, CE, CTEK, FTS, IMMR)

Analysts’ updated eps estimates for Monday, January 29th:

AbbVie (NYSE:ABBV) had its neutral rating reiterated by analysts at Credit Suisse Group AG. Credit Suisse Group AG currently has a $135.00 target price on the stock, up from their previous target price of $98.00.

Dawson James assumed coverage on shares of Acasti Pharma (NASDAQ:ACST). They issued a buy rating on the stock.

Air Products & Chemicals (NYSE:APD) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $195.00 target price on the stock.

Aryzta (OTCMKTS:ARZTY) was downgraded by analysts at Goldman Sachs Group Inc from a neutral rating to a sell rating.

Alibaba Group (NYSE:BABA) had its in-line rating reissued by analysts at Morgan Stanley. The firm currently has a $250.00 target price on the stock, up from their previous target price of $220.00.

Bristol-Myers Squibb (NYSE:BMY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Bristol-Myers’ blockbuster drug Opdivo is facing competitive challenges in the United States. With the FDA approving Merck’s Keytruda, for the first-line treatment of metastatic non-squamous NSCLC, the competition will stiffen up.  Pricing concerns, stiff competition in the HCV and immuno-oncology space are expected to remain a significant overhang on the company’s shares. Yervoy’s sales are expected to be under pressure due to adoption of Opdivo in adjuvant melanoma. Gross margin is also expected to be under pressure due to product mix and declines in virology business. Shares of the company have underperformed the industry in the last three months. Estimates have remained stable ahead of Q4 earnings. The company has a mixed record of earnings surprises in the recent quarters.”

Celanese (NYSE:CE) had its buy rating reissued by analysts at Jefferies Group LLC. They currently have a $130.00 target price on the stock.

Roth Capital initiated coverage on shares of CynergisTek (NYSEAMERICAN:CTEK). The firm issued a buy rating and a $7.20 target price on the stock.

Fortis (NYSE:FTS) was downgraded by analysts at National Bank Financial from a sector perform rating to an underperform rating.

Immersion (NASDAQ:IMMR) had its buy rating reissued by analysts at Craig Hallum. The firm currently has a $15.00 price target on the stock, up from their previous price target of $12.00.

KLA-Tencor (NASDAQ:KLAC) had its outperform rating reiterated by analysts at Credit Suisse Group AG. Credit Suisse Group AG currently has a $134.00 target price on the stock, up from their previous target price of $124.00.

Lear (NYSE:LEA) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $231.00 price target on the stock.

MGP Ingredients (NASDAQ:MGPI) had its buy rating reaffirmed by analysts at Craig Hallum. The firm currently has a $105.00 target price on the stock, up from their previous target price of $90.00.

Moog (NYSE:MOG) had its underperform rating reiterated by analysts at Credit Suisse Group AG. The firm currently has a $82.00 price target on the stock, up from their previous price target of $75.00.

Tractor Supply (NASDAQ:TSCO) had its neutral rating reiterated by analysts at Credit Suisse Group AG. They currently have a $73.00 price target on the stock, up from their previous price target of $52.00.

UBM (OTCMKTS:UBMOF) was downgraded by analysts at Citigroup Inc from a buy rating to a neutral rating.

Domtar (NYSE:UFS) (TSE:UFS) was downgraded by analysts at UFS from an outperform rating to a market perform rating.

Wynn Resorts (NASDAQ:WYNN) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating.

Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply